Drug Insight: new drugs in development for Parkinson's disease.
about
Current status of symptomatic medical therapy in Parkinson's diseaseNeurotransmission in Parkinson's disease: beyond dopamine.Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.Which dyskinesia scale best detects treatment response?Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease.
P2860
Drug Insight: new drugs in development for Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Drug Insight: new drugs in development for Parkinson's disease.
@ast
Drug Insight: new drugs in development for Parkinson's disease.
@en
type
label
Drug Insight: new drugs in development for Parkinson's disease.
@ast
Drug Insight: new drugs in development for Parkinson's disease.
@en
prefLabel
Drug Insight: new drugs in development for Parkinson's disease.
@ast
Drug Insight: new drugs in development for Parkinson's disease.
@en
P2860
P50
P356
P1476
Drug Insight: new drugs in development for Parkinson's disease.
@en
P2860
P304
P356
10.1038/NCPNEURO0340
P577
2006-11-01T00:00:00Z